Endocrinology and Metabolism
The Division of Endocrinology/Metabolism provides comprehensive diagnosis and treatment of cancers and diseases of the pituitary, thyroid, parathyroid, and adrenal glands.
Specialized services are provided for diagnosis and treatment of diabetes, thyroid cancer, Polycystic Ovarian Syndrome (PCOS), and osteoporosis.
A metabolic disorder is a medical disorder that affects the production of energy within individual cells. The main features of metabolic syndrome include insulin resistance, hypertension (high blood pressure), cholesterol abnormalities and an increased risk for clotting.
Most metabolic disorders are genetic, though a few are "acquired" as a result of diet, toxins and infections. Patients are most often overweight or obese. Type 2 Diabetes, or diabetes mellitus type 2, is the most commonly known metabolic disorder.
Our physicians provide care for many medical conditions including (but not limited to) the following:
Your endocrine system is a complex system of hormones that regulates many of your body’s functions. The endocrine system includes:
The Division of Endocrinology/Metabolism provides the highest quality care while ensuring patient care and comfort. We provide clinical care for a full range of endocrine hormonal disorders and cancer including:
Meet Our Team
675 North St Clair
Chicago, Illinois 60611
Monday: 7 a.m. to 7 p.m.
Tuesday: 8 a.m. to 5 p.m.
Wednesday: 8 a.m. to 5 p.m.
Thursday: 7 a.m. to 3 p.m.
Friday: 7 a.m. to 5 p.m.
In the News
How the Circadian Clock Controls Insulin and Blood Sugar Regulation in the Pancreas
Joe Bass, MD, PhD, chief of Endocrinology in the Department of Medicine, was principal investigator of a study that revealed thousands of genes in the pancreas that the circadian clock’s transcription factors control in rhythm with the planet’s daily rotation from light to dark.
Data Mining DNA for Polycystic Ovary Syndrome Genes
Andrea Dunaif, MD, Charles F. Kettering Professor of Endocrinology and Metabolism, and M. Geoffrey Hayes, PhD, assistant professor in endocrinology, have led the first study of its kind to investigate Polycystic Ovary Syndrome (PCOS) in the genomes of women of European ancestry. PCOS affects seven to 10 percent of women and there is no FDA-approved treatment or cure.